Table 1.
Cellular mechanisms that are potentially applicable for genetic engineering of GP migration.
Mechanism | Molecule/medium | Cell type | Reference |
---|---|---|---|
Attraction | CD44 | Astrocyte precursor | Bourguignon et al., 2007 |
CXCL16/CXCR4 axis | CXCR6-positive GP | Hattermann et al. 2008 | |
PDGF | Oligodendrocyte precursor | Armstrong et al., 1990 | |
SDF-1-CXC-4 | Hematopoetic stem cell | Janowski. 2009 | |
MSC | Nowakowski et al., 2016 | ||
EPC | Li et al., 2012 | ||
HGF-c-Met | Tumor cell | Wallace et al., 2013 | |
IGF-1 | Cardiac stem cell | O’Neill ey al., 2016 | |
Vascular smooth muscle cell | Beneit et al., 2016 | ||
Repulsion | CSPGs | GP | Yuan et al., 2016 |
Nestrin 1 | Small NG2-positive GP | Sugimoto et al., 2001 | |
Sema3a | Large NG2-positive GP | Sugimoto et al., 2001 | |
Glioma cell line | Nasarre et al., 2009 | ||
TGFβ1 | OPC | Choe et al., 2009 | |
EGF | Newborn glia | Kuhn et al., 2009 | |
Motility regulation | AQP4 | Astroglia | Ding et al, 2011 |
NCAM | GP | Wang et al. 1994 | |
Sox5 and Sox6 | Oligodendroglial cell | Baroti et al., 2016 | |
ZEB-1 | Epithelial cancer cell | Zhang et al., 2015 | |
NSC | Kahlert et al., 2015 | ||
Electric field | Schwann cells, MSCs, and pluripotent stem cells | Iwasa et al. 2017 | |
OPC | Zhu et al. 2016 |